Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

ATROPINE SULFATE

ATROPINE SULFATE

Standard Dose
0.25MG/5ML (0.05MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ATROPINE SULFATE is listed in Drugs@FDA under application 212868 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ATROPINE SULFATE Form and strength SOLUTION;INTRAVENOUS - 0.25MG/5ML (0.05MG/ML) Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2026-03-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview ATROPINE SULFATE is listed in Drugs@FDA under application 212868 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ATROPINE SULFATE Form and strength SOLUTION;INTRAVENOUS - 0.25MG/5ML (0.05MG/ML) Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2026-03-18 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.